Mettler-Toledo International
Mettler-Toledo International Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$4.0B
Operating marginCalculated
Could not be retrieved
Net assets to total assetsCalculated
-0.6%
Company profile
Tables scroll sideways
Disclosed data
Profitability
Could not be retrieved
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.0%
Capital efficiency
★☆☆☆☆position among all companies
-3677.4%
Revenue and profit
Performance, financial position and capital allocation
Mettler-Toledo International
Recent performance trends
Mettler-Toledo International
Cash flow trends
Consolidated indicators (8 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$3.7 billion | US$3.9 billion | US$3.8 billion | US$3.9 billion | US$4.0 billion |
| Net income | US$0.8 billion | US$0.9 billion | US$0.8 billion | US$0.9 billion | US$0.9 billion |
| Total assets | US$3.3 billion | US$3.5 billion | US$3.4 billion | US$3.2 billion | US$3.7 billion |
| Shareholders' equity | US$0.2 billion | US$24.79 million | US$-0.1 billion | US$-0.1 billion | US$-23.64 million |
| Net cash provided by (used in) operating activities | US$0.9 billion | US$0.9 billion | US$1.0 billion | US$1.0 billion | US$1.0 billion |
| Net cash provided by (used in) investing activities | US$-0.3 billion | US$-0.1 billion | US$-0.1 billion | US$-0.1 billion | US$-0.2 billion |
| Net cash provided by (used in) financing activities | US$-0.6 billion | US$-0.7 billion | US$-0.9 billion | US$-0.9 billion | US$-0.8 billion |
| Cash and cash equivalents | US$98.56 million | US$95.97 million | US$69.81 million | US$59.36 million | US$66.89 million |
Revenue scale in the same industry
Mettler-Toledo International
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 29 companies
- 33 The Cooper CompaniesFY Oct 2025 US$4.1B
- 34 Align TechnologyFY Dec 2025 US$4.0B
- 35 Mettler-Toledo InternationalThis companyFY Dec 2025 US$4.0B
- 36 MKSFY Dec 2025 US$3.9B
- 37 Dentsply SironaFY Dec 2025 US$3.7B
- … 6 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.1 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$66.89 million | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.8 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$1.0 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$51.14 million | Consolidated | Disclosed |
| Net assets | US$-23.64 million | Consolidated | Disclosed |
| Net sales | US$4.0 billion | Consolidated | Disclosed |
| Net income | US$0.9 billion | Consolidated | Disclosed |
| Total assets | US$3.7 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.8 billion | Consolidated | Disclosed |
| Operating margin | Cannot be calculated | Not applicable | Not calculated (no operating income in this year's 10-K) |
| Net assets to total assets | -0.6% | Consolidated | Calculated |
| Net margin | 21.6% | Consolidated | Calculated |
| Return on equity | -3677.4% | Consolidated | Calculated |